Related Experiment Videos
Studies on the mechanism by which galanin inhibits insulin secretion in islets
1Department of Pharmacology, Lund University, Sweden.
Abstract:
The mechanism by which the neuropeptide galanin inhibits insulin secretion in normal islets is not yet fully elucidated. Isolated rat or mouse islets were perifused in a medium containing glucose (8.3 mM) and galanin (10(-6) M) or the sulphonamide diazoxide (400 microM). In rat islets prelabelled with 86Rb+ or 45Ca2+, galanin inhibited glucose-induced insulin secretion at the same time as increasing 86Rb+ efflux and reducing 45Ca2+ efflux. The diazoxide-induced 86Rb+ efflux was not affected by galanin, indicating that galanin activates ATP-regulated K+ channels in rat islets. In mouse islets prelabelled with 86Rb+, galanin (10(-6) M) decreased 86Rb+ efflux. These results suggest that galanin inhibits insulin release in isolated islets by increasing K+ and decreasing Ca2+ permeability. The increased K+ permeability, which is probably regulated differently in rat and mouse islets, is followed by a reduced Ca2+ influx, possibly through voltage-dependent Ca2+ channels. In addition, during a 60-min incubation with isolated islets, galanin inhibited insulin secretion induced by forskolin (1 microM), dibutyryl cyclic AMP (1 mM), or TPA (12-O-tetradecanoylphorbol-13-acetate; 0.1 microM). Galanin also reduced the content of cyclic AMP in islets stimulated by 16.7 mM glucose. We therefore conclude that the inhibitory action of galanin on insulin secretion in normal islets includes increasing K+ permeability as well as interference with the activation of adenylate cyclase and the activity of protein kinase C and cyclic AMP.
Insights
Galanin inhibits insulin secretion by increasing potassium permeability and reducing calcium influx in islets. It also interferes with cyclic AMP and protein kinase C pathways, impacting glucose regulation.
Area of Science:
- Endocrinology
- Molecular Biology
- Cell Physiology
Background:
- The precise mechanisms by which galanin inhibits insulin secretion in pancreatic islets remain incompletely understood.
- Galanin is a neuropeptide implicated in various physiological processes, including glucose homeostasis.
Purpose of the Study:
- To elucidate the cellular and molecular mechanisms underlying galanin's inhibitory effect on insulin secretion in normal islets.
- To investigate the role of ion channel activity and intracellular signaling pathways in galanin's action.
Main Methods:
- Perfusion of isolated rat and mouse islets with glucose and galanin.
- Measurement of 86Rb+ efflux and 45Ca2+ efflux to assess ion permeability.
- Assessment of insulin secretion in response to various secretagogues (glucose, forskolin, dibutyryl cyclic AMP, TPA).
- Quantification of intracellular cyclic AMP levels.
Main Results:
- Galanin increased 86Rb+ efflux and decreased 45Ca2+ efflux in rat islets, indicating activation of ATP-regulated K+ channels and reduced Ca2+ influx.
- Galanin decreased 86Rb+ efflux in mouse islets, suggesting species-specific regulation of K+ channels.
- Galanin inhibited insulin secretion stimulated by glucose, forskolin, dibutyryl cyclic AMP, and TPA.
- Galanin reduced glucose-stimulated cyclic AMP levels in islets.
Conclusions:
- Galanin inhibits insulin secretion by increasing K+ permeability and reducing Ca2+ influx, likely via voltage-dependent Ca2+ channels.
- The action of galanin on K+ channels differs between rat and mouse islets.
- Galanin interferes with adenylate cyclase activation and protein kinase C activity, further contributing to insulin secretion inhibition.